ID   ABHD5_MOUSE             Reviewed;         351 AA.
AC   Q9DBL9; Q9CTY3;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   07-APR-2021, entry version 152.
DE   RecName: Full=1-acylglycerol-3-phosphate O-acyltransferase ABHD5 {ECO:0000305};
DE            EC=2.3.1.51 {ECO:0000250|UniProtKB:Q8WTS1};
DE   AltName: Full=Abhydrolase domain-containing protein 5;
DE   AltName: Full=Lipid droplet-binding protein CGI-58;
DE            Short=Protein CGI-58;
GN   Name=Abhd5 {ECO:0000312|MGI:MGI:1914719};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Liver;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=FVB/N; TISSUE=Colon, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH PLIN, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15292255; DOI=10.1074/jbc.m407462200;
RA   Subramanian V., Rothenberg A., Gomez C., Cohen A.W., Garcia A.,
RA   Bhattacharyya S., Shapiro L., Dolios G., Wang R., Lisanti M.P.,
RA   Brasaemle D.L.;
RT   "Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in
RT   3T3-L1 adipocytes.";
RL   J. Biol. Chem. 279:42062-42071(2004).
RN   [4]
RP   FUNCTION, TISSUE SPECIFICITY, AND INTERACTION WITH PLIN AND PNPLA2.
RX   PubMed=16679289; DOI=10.1016/j.cmet.2006.03.005;
RA   Lass A., Zimmermann R., Haemmerle G., Riederer M., Schoiswohl G.,
RA   Schweiger M., Kienesberger P., Strauss J.G., Gorkiewicz G., Zechner R.;
RT   "Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is
RT   activated by CGI-58 and defective in Chanarin-Dorfman Syndrome.";
RL   Cell Metab. 3:309-319(2006).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18832586; DOI=10.2353/ajpath.2008.080005;
RA   Akiyama M., Sakai K., Takayama C., Yanagi T., Yamanaka Y., McMillan J.R.,
RA   Shimizu H.;
RT   "CGI-58 is an alpha/beta-hydrolase within lipid transporting lamellar
RT   granules of differentiated keratinocytes.";
RL   Am. J. Pathol. 173:1349-1360(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=18606822; DOI=10.1074/jbc.m801783200;
RA   Ghosh A.K., Ramakrishnan G., Chandramohan C., Rajasekharan R.;
RT   "CGI-58, the causative gene for Chanarin-Dorfman syndrome, mediates
RT   acylation of lysophosphatidic acid.";
RL   J. Biol. Chem. 283:24525-24533(2008).
RN   [7]
RP   INTERACTION WITH PLIN5.
RX   PubMed=19064991; DOI=10.1074/jbc.m808251200;
RA   Granneman J.G., Moore H.P., Mottillo E.P., Zhu Z.;
RT   "Functional interactions between Mldp (LSDP5) and Abhd5 in the control of
RT   intracellular lipid accumulation.";
RL   J. Biol. Chem. 284:3049-3057(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Pancreas, Spleen,
RC   and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [9]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION,
RP   FUNCTION, AND SUBSTRATE SPECIFICITY.
RX   PubMed=19801371; DOI=10.1194/jlr.m001917;
RA   Montero-Moran G., Caviglia J.M., McMahon D., Rothenberg A., Subramanian V.,
RA   Xu Z., Lara-Gonzalez S., Storch J., Carman G.M., Brasaemle D.L.;
RT   "CGI-58/ABHD5 is a coenzyme A-dependent lysophosphatidic acid
RT   acyltransferase.";
RL   J. Lipid Res. 51:709-719(2010).
RN   [10]
RP   INTERACTION WITH PLIN5.
RX   PubMed=21148142; DOI=10.1074/jbc.m110.180711;
RA   Granneman J.G., Moore H.P., Mottillo E.P., Zhu Z., Zhou L.;
RT   "Interactions of perilipin-5 (Plin5) with adipose triglyceride lipase.";
RL   J. Biol. Chem. 286:5126-5135(2011).
RN   [11]
RP   FUNCTION.
RX   PubMed=26083785; DOI=10.1371/journal.pgen.1005284;
RA   Xie M., Roy R.;
RT   "The causative gene in Chanarian Dorfman syndrome regulates lipid droplet
RT   homeostasis in C. elegans.";
RL   PLoS Genet. 11:E1005284-E1005284(2015).
RN   [12]
RP   ERRATUM OF PUBMED:26083785.
RX   PubMed=28002418; DOI=10.1371/journal.pgen.1006524;
RA   Xie M., Roy R.;
RL   PLoS Genet. 12:E1006524-E1006524(2016).
CC   -!- FUNCTION: Coenzyme A-dependent lysophosphatidic acid acyltransferase
CC       that catalyzes the transfert of an acyl group on a lysophosphatidic
CC       acid (PubMed:19801371). Functions preferentially with 1-oleoyl-
CC       lysophosphatidic acid followed by 1-palmitoyl-lysophosphatidic acid, 1-
CC       stearoyl-lysophosphatidic acid and 1-arachidonoyl-lysophosphatidic acid
CC       as lipid acceptor (PubMed:19801371). Functions preferentially with
CC       arachidonoyl-CoA followed by oleoyl-CoA as acyl group donors
CC       (PubMed:19801371). Functions in phosphatidic acid biosynthesis (By
CC       similarity). May regulate the cellular storage of triacylglycerol
CC       through activation of the phospholipase PNPLA2 (PubMed:16679289).
CC       Involved in keratinocyte differentiation (By similarity). Regulates
CC       lipid droplet fusion (PubMed:26083785). {ECO:0000250|UniProtKB:Q8WTS1,
CC       ECO:0000269|PubMed:16679289, ECO:0000269|PubMed:19801371,
CC       ECO:0000269|PubMed:26083785}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphate + an acyl-CoA = a 1,2-diacyl-
CC         sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:19709,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57970, ChEBI:CHEBI:58342,
CC         ChEBI:CHEBI:58608; EC=2.3.1.51;
CC         Evidence={ECO:0000250|UniProtKB:Q8WTS1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19710;
CC         Evidence={ECO:0000250|UniProtKB:Q8WTS1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphate = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37131, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74546;
CC         Evidence={ECO:0000269|PubMed:19801371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37132;
CC         Evidence={ECO:0000305|PubMed:19801371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + hexadecanoyl-CoA
CC         = 1-(9Z)-octadecenoyl-2-hexadecanoyl-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37143, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74551;
CC         Evidence={ECO:0000269|PubMed:19801371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37144;
CC         Evidence={ECO:0000305|PubMed:19801371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + octadecanoyl-CoA
CC         = 1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37147, ChEBI:CHEBI:57287, ChEBI:CHEBI:57394,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74552;
CC         Evidence={ECO:0000269|PubMed:19801371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37148;
CC         Evidence={ECO:0000305|PubMed:19801371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(9Z-octadecenoyl)-sn-
CC         glycero-3-phosphate = 1-(9Z)-octadecenoyl-2-(5Z,8Z,11Z,14Z)-
CC         eicosatetraenoyl-sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37443,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:74544,
CC         ChEBI:CHEBI:74928; Evidence={ECO:0000269|PubMed:19801371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37444;
CC         Evidence={ECO:0000305|PubMed:19801371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + eicosanoyl-CoA =
CC         1-(9Z)-octadecenoyl-2-eicosanoyl-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37451, ChEBI:CHEBI:57287, ChEBI:CHEBI:57380,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74937;
CC         Evidence={ECO:0000269|PubMed:19801371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37452;
CC         Evidence={ECO:0000305|PubMed:19801371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-phosphate
CC         = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:33187, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:57518, ChEBI:CHEBI:64839;
CC         Evidence={ECO:0000269|PubMed:19801371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33188;
CC         Evidence={ECO:0000305|PubMed:19801371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-octadecanoyl-sn-glycero-3-phosphate
CC         = 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37163, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:74560, ChEBI:CHEBI:74565;
CC         Evidence={ECO:0000269|PubMed:19801371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37164;
CC         Evidence={ECO:0000305|PubMed:19801371};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-
CC         glycero-3-phosphate = 1-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-2-(9Z)-
CC         octadecenoyl-sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37455,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:74938,
CC         ChEBI:CHEBI:74941; Evidence={ECO:0000269|PubMed:19801371};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37456;
CC         Evidence={ECO:0000305|PubMed:19801371};
CC   -!- ACTIVITY REGULATION: Acyltransferase activity is inhibited by
CC       detergents such as Triton X-100 and 3-[(3-
CC       cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS).
CC       Acyltransferase activity is inhibited by the presence of magnesium and
CC       calcium. {ECO:0000269|PubMed:19801371}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.8 uM for oleoyl-CoA {ECO:0000269|PubMed:19801371};
CC         KM=18 uM for 1-oleoyl-lysophosphatidic acid
CC         {ECO:0000269|PubMed:19801371};
CC         Vmax=6.1 nmol/min/mg enzyme toward oleoyl-CoA
CC         {ECO:0000269|PubMed:19801371};
CC         Vmax=7.6 nmol/min/mg enzyme toward 1-oleoyl-lysophosphatidic acid
CC         {ECO:0000269|PubMed:19801371};
CC       pH dependence:
CC         Optimum pH is 7-8.5. {ECO:0000269|PubMed:19801371};
CC       Temperature dependence:
CC         Preincubation of the enzyme for 10 min at temperatures above 35
CC         degrees Celsius decreases acyltransferase activity subsequently
CC         measured at 30 degrees Celsius. Acyltransferase activity is reduced
CC         by approximately 60% following 10 min preincubation at47 degrees
CC         Celsius. {ECO:0000269|PubMed:19801371};
CC   -!- SUBUNIT: Interacts with ADRP (By similarity). Interacts with PLIN.
CC       Interacts with and PNPLA2. Interacts with PLIN5; promotes interaction
CC       with PNPLA2. {ECO:0000250, ECO:0000269|PubMed:15292255,
CC       ECO:0000269|PubMed:16679289, ECO:0000269|PubMed:19064991,
CC       ECO:0000269|PubMed:21148142}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Lipid droplet
CC       {ECO:0000269|PubMed:18606822}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:18606822}. Note=Colocalized with PLIN and ADRP on
CC       the surface of lipid droplets. The localization is dependent upon the
CC       metabolic status of the adipocytes and the activity of PKA.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9DBL9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9DBL9-2; Sequence=VSP_015345;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the adipose tissue and testes.
CC       Weakly expressed in the liver, muscle, kidney, and heart. Expressed by
CC       upper epidermal layers and dermal fibroblasts in skin, hepatocytes and
CC       hypothalamus in brain (at protein level). {ECO:0000269|PubMed:15292255,
CC       ECO:0000269|PubMed:16679289, ECO:0000269|PubMed:18832586}.
CC   -!- DOMAIN: The HXXXXD motif is essential for acyltransferase activity and
CC       may constitute the binding site for the phosphate moiety of the
CC       glycerol-3-phosphate. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase S33 family. ABHD4/ABHD5 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK004873; BAB23632.1; -; mRNA.
DR   EMBL; AK019488; BAB31755.2; -; mRNA.
DR   EMBL; AK050377; BAC34220.1; -; mRNA.
DR   EMBL; BC037063; AAH37063.1; -; mRNA.
DR   CCDS; CCDS23646.1; -. [Q9DBL9-1]
DR   CCDS; CCDS90688.1; -. [Q9DBL9-2]
DR   RefSeq; NP_080455.1; NM_026179.2. [Q9DBL9-1]
DR   RefSeq; XP_006512308.1; XM_006512245.3.
DR   PDB; 5A4H; NMR; -; A=10-43.
DR   PDBsum; 5A4H; -.
DR   SMR; Q9DBL9; -.
DR   BioGRID; 212211; 4.
DR   DIP; DIP-61642N; -.
DR   IntAct; Q9DBL9; 1.
DR   STRING; 10090.ENSMUSP00000122274; -.
DR   ChEMBL; CHEMBL3259509; -.
DR   SwissLipids; SLP:000000283; -.
DR   ESTHER; mouse-abhd5; CGI-58_ABHD5_ABHD4.
DR   MEROPS; S33.975; -.
DR   iPTMnet; Q9DBL9; -.
DR   PhosphoSitePlus; Q9DBL9; -.
DR   SwissPalm; Q9DBL9; -.
DR   jPOST; Q9DBL9; -.
DR   PaxDb; Q9DBL9; -.
DR   PeptideAtlas; Q9DBL9; -.
DR   PRIDE; Q9DBL9; -.
DR   ProteomicsDB; 286052; -. [Q9DBL9-1]
DR   ProteomicsDB; 286053; -. [Q9DBL9-2]
DR   Antibodypedia; 29395; 333 antibodies.
DR   Ensembl; ENSMUST00000111497; ENSMUSP00000107123; ENSMUSG00000032540. [Q9DBL9-2]
DR   Ensembl; ENSMUST00000156520; ENSMUSP00000122274; ENSMUSG00000032540. [Q9DBL9-1]
DR   GeneID; 67469; -.
DR   KEGG; mmu:67469; -.
DR   UCSC; uc009sew.1; mouse. [Q9DBL9-1]
DR   UCSC; uc009sey.1; mouse. [Q9DBL9-2]
DR   CTD; 51099; -.
DR   MGI; MGI:1914719; Abhd5.
DR   eggNOG; KOG4409; Eukaryota.
DR   GeneTree; ENSGT00390000016277; -.
DR   HOGENOM; CLU_017361_0_0_1; -.
DR   InParanoid; Q9DBL9; -.
DR   OMA; SCDPGAQ; -.
DR   OrthoDB; 1555935at2759; -.
DR   PhylomeDB; Q9DBL9; -.
DR   TreeFam; TF314196; -.
DR   BRENDA; 2.3.1.51; 3474.
DR   BioGRID-ORCS; 67469; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; Abhd5; mouse.
DR   PRO; PR:Q9DBL9; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; Q9DBL9; protein.
DR   Bgee; ENSMUSG00000032540; Expressed in spermatid and 308 other tissues.
DR   ExpressionAtlas; Q9DBL9; baseline and differential.
DR   Genevisible; Q9DBL9; MM.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0005811; C:lipid droplet; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0052689; F:carboxylic ester hydrolase activity; IBA:GO_Central.
DR   GO; GO:0042171; F:lysophosphatidic acid acyltransferase activity; ISO:MGI.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0055088; P:lipid homeostasis; IBA:GO_Central.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:MGI.
DR   GO; GO:0010891; P:negative regulation of sequestering of triglyceride; IDA:UniProtKB.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0050996; P:positive regulation of lipid catabolic process; IMP:CACAO.
DR   GO; GO:0051006; P:positive regulation of lipoprotein lipase activity; IDA:MGI.
DR   GO; GO:0010898; P:positive regulation of triglyceride catabolic process; IDA:UniProtKB.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000073; AB_hydrolase_1.
DR   Pfam; PF00561; Abhydrolase_1; 1.
DR   PRINTS; PR00111; ABHYDROLASE.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Alternative splicing; Cytoplasm;
KW   Differentiation; Fatty acid metabolism; Lipid biosynthesis; Lipid droplet;
KW   Lipid metabolism; Phospholipid biosynthesis; Phospholipid metabolism;
KW   Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN           1..351
FT                   /note="1-acylglycerol-3-phosphate O-acyltransferase ABHD5"
FT                   /id="PRO_0000080867"
FT   DOMAIN          79..184
FT                   /note="AB hydrolase-1"
FT                   /evidence="ECO:0000255"
FT   MOTIF           329..334
FT                   /note="HXXXXD motif"
FT   MOD_RES         124
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6QA69"
FT   VAR_SEQ         19..171
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_015345"
FT   HELIX           21..23
FT                   /evidence="ECO:0007744|PDB:5A4H"
FT   STRAND          39..41
FT                   /evidence="ECO:0007744|PDB:5A4H"
SQ   SEQUENCE   351 AA;  39155 MW;  04068BFB77D33E67 CRC64;
     MKAMAAEEEV DSADAGGGSG WLTGWLPTWC PTSTSHLKEA EEKMLKCVPC TYKKEPVRIS
     NGNRIWTLMF SHNISSKTPL VLLHGFGGGL GLWALNFEDL STDRPVYAFD LLGFGRSSRP
     RFDSDAEEVE NQFVESIEEW RCALRLDKMI LLGHNLGGFL AAAYSLKYPS RVSHLILVEP
     WGFPERPDLA DQERPIPVWI RALGAALTPF NPLAGLRIAG PFGLSLVQRL RPDFKRKYSS
     MFEDDTVTEY IYHCNVQTPS GETAFKNMTI PYGWAKRPML QRIGGLHPDI PVSVIFGARS
     CIDGNSGTSI QSLRPKSYVK TIAILGAGHY VYADQPEEFN QKVKEICHTV D
//
